PT90249A - Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t - Google Patents

Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t

Info

Publication number
PT90249A
PT90249A PT90249A PT9024989A PT90249A PT 90249 A PT90249 A PT 90249A PT 90249 A PT90249 A PT 90249A PT 9024989 A PT9024989 A PT 9024989A PT 90249 A PT90249 A PT 90249A
Authority
PT
Portugal
Prior art keywords
oxindole
carboxamides
substituted
cell
mammal
Prior art date
Application number
PT90249A
Other languages
English (en)
Other versions
PT90249B (pt
Inventor
Henry James Showell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT90249A publication Critical patent/PT90249A/pt
Publication of PT90249B publication Critical patent/PT90249B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT90249A 1988-04-13 1989-04-11 Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t PT90249B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (2)

Publication Number Publication Date
PT90249A true PT90249A (pt) 1989-11-10
PT90249B PT90249B (pt) 1994-06-30

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90249A PT90249B (pt) 1988-04-13 1989-04-11 Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t

Country Status (17)

Country Link
US (1) US4853409A (pt)
EP (1) EP0337628B1 (pt)
JP (1) JPH01311022A (pt)
KR (1) KR920002328B1 (pt)
AT (1) ATE89725T1 (pt)
AU (1) AU601326B2 (pt)
CA (1) CA1324762C (pt)
DE (1) DE68906707T2 (pt)
DK (1) DK174289A (pt)
HU (1) HU204996B (pt)
IE (1) IE62751B1 (pt)
IL (1) IL89872A (pt)
MY (1) MY103872A (pt)
NZ (1) NZ228712A (pt)
PH (1) PH25857A (pt)
PT (1) PT90249B (pt)
ZA (1) ZA892622B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
CN1116822A (zh) * 1993-01-22 1996-02-14 美国辉瑞有限公司 6-氯-5-氟-3-(2-噻吩甲酰)-2-羟吲哚-1-羰酰胺的赖氨酸盐
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
SK281254B6 (sk) * 1995-07-13 2001-01-18 Smithkline Beecham Corporation Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
WO1988005656A1 (en) * 1987-02-02 1988-08-11 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Also Published As

Publication number Publication date
DE68906707D1 (de) 1993-07-01
ATE89725T1 (de) 1993-06-15
EP0337628A3 (en) 1991-01-02
CA1324762C (en) 1993-11-30
DE68906707T2 (de) 1993-09-16
HU204996B (en) 1992-03-30
IE891171L (en) 1989-10-13
KR920002328B1 (ko) 1992-03-21
PH25857A (en) 1991-12-02
IE62751B1 (en) 1995-02-22
AU3271289A (en) 1989-10-19
DK174289A (da) 1989-10-16
HUT52376A (en) 1990-07-28
EP0337628B1 (en) 1993-05-26
IL89872A (en) 1994-06-24
AU601326B2 (en) 1990-09-06
JPH01311022A (ja) 1989-12-15
KR890015740A (ko) 1989-11-25
IL89872A0 (en) 1989-12-15
MY103872A (en) 1993-09-30
US4853409A (en) 1989-08-01
DK174289D0 (da) 1989-04-12
EP0337628A2 (en) 1989-10-18
ZA892622B (en) 1990-11-28
PT90249B (pt) 1994-06-30
NZ228712A (en) 1997-02-24

Similar Documents

Publication Publication Date Title
PT90249A (pt) Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t
DK1319669T3 (da) Kemisk modificeret vævsinhibitor af type-3-metalloproteinase- (TIMP-3) sammensætning samt fremgangsmåder
SE7903186L (sv) Cerebralverksamt medel
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
IT8320435A0 (it) Composizione per il trattamento dell'acne.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
DK174389A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
GR3006674T3 (pt)
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
DK162839C (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og 3-acyl-2-oxindol-forbindelser til anvendelse som mellemprodukter ved deres fremstilling
IL90100A0 (en) Certain paf antagonist/antihistamine combinations and methods
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
ES2052701T3 (es) Agente hipouricemico que contiene ponalrestat.
IT8619249A0 (it) Kit per la determinazione dell'attivita' proliferativa nei tumori umani.
ES2053808T3 (es) Nuevos compuestos azolicos.
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8024828A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella terapia della iperlattacidemia.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
IT8220082A0 (it) Composizione atta al trattamento terapeutico dei tumori.
IT8647570A0 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne giovanile

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931206

MM3A Annulment or lapse

Effective date: 20050606